Reactive oxygen species and IRF1 stimulate IFNα production by proximal tubules during ischemic AKI

American Journal of Physiology - Renal Physiology

Volumn 305, Issue 2, 2013, Pages

  Winterberg, Pamela D ^a   Wang, Yanxia ^a   Lin, Keng Mean ^a   Hartono, John R ^a   Nagami, Glenn T ^c   Zhou, Xin J ^a   Shelton, John M ^a   Richardson, James A ^a   Lu, Christopher Y ^a,b  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

AKI; Innate immunity; Type I interferon

Indexed keywords

ALPHA INTERFERON; BETA INTERFERON; CREATININE; CXCL2 CHEMOKINE; INTERFERON RECEPTOR; INTERFERON REGULATORY FACTOR 1; REACTIVE OXYGEN METABOLITE; SMALL INTERFERING RNA;

ACUTE KIDNEY FAILURE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; IMMUNOHISTOLOGY; IN VITRO STUDY; INTERFERON PRODUCTION; KIDNEY FUNCTION; KIDNEY ISCHEMIA; KIDNEY PROXIMAL TUBULE; KIDNEY TUBULE; KIDNEY TUBULE CELL; LEUKOCYTE; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION;

EID: 84880176736     PISSN: 1931857X     EISSN: 15221466     Source Type: Journal    
DOI: 10.1152/ajprenal.00487.2012     Document Type: Article

References (61)

1. Bonventre JV, Zuk A. Ischemic acute renal failure: an inflammatory disease? Kidney Int 66: 480-485, 2004.
2. Bookout AL, Cummins CL, Mangelsdorf DJ, Pesola JM, Kramer MF. High-throughput real-time quantitative reverse transcription PCR. Curr Protoc Mol Biol 15: 15-18, 2006.
3. Brzostek-Racine S, Gordon C, Van Scoy S, Reich NC. The DNA damage response induces IFN. J Immunol 187: 5336-5345, 2011.
4. Carey MF, Peterson CL, Smale ST. Confirming the functional importance of a rotein-DNA interaction. In: Transcriptional Regulation in Eukaryotes. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press, 2009, p. 237-260.
5. Chen J, Hartono J, John R, Bennett M, Zhou X, Wang Y, Wu Q, Winterberg P, Nagami GT, Lu CY. Interleukin 6 production by leukocytes during ischemic acute kidney injury is regulated by TLR4. Kidney Int 80: 504-515, 2011.
6. Chertow GM, Burdick E, Honour M, Bonventre JV, Bates DW. Acute kidney injury, mortality, length of stay, and costs in hospitalized patients. J Am Soc Nephrol 16: 3365-3370, 2005.
7. de Weerd NA, Nguyen T. The interferons and their receptors-distribution and regulation. Immunol Cell Biol 90: 483-491, 2012.
8. Droge W. Free radicals in the physiological control of cell function. Physiol Rev 82: 47-95, 2002.
9. Ernest S, Bello-Reuss E. Expression and function of P-glycoprotein in a mouse kidney cell line. Am J Physiol Cell Physiol 269: C323-C333, 1995.
10. Ford E, Thanos D. The transcriptional code of human IFN-beta gene expression. Biochim Biophys Acta 1799: 328-336, 2010.
11. Freitas MC, Uchida Y, Lassman C, Danovitch GM, Busuttil RW, Kupiec-Weglinski JW. Type I interferon pathway mediates renal ischemia/ reperfusion injury. Transplantation 92: 131-138, 2011.
12. Galluzzi L, Blomgren K, Kroemer G. Mitochondrial membrane permeabilization in neuronal injury. Nat Rev Neurosci 10: 481-494, 2009.
13. Hall AM. Pores for thought: new strategies to re-energize stressed mitochondria in acute kidney injury. J Am Soc Nephrol 22: 986-989, 2011.
14. Halliwell B. Biochemistry of oxidative stress. Biochem Soc Trans 35: 1147-1150, 2007.
15. Hsu CY. Yes, AKI truly leads to CKD. J Am Soc Nephrol 23: 967-969, 2012.
16. Jang HR, Rabb H. The innate immune response in ischemic acute kidney injury. Clin Immunol 130: 41-50, 2009.
17. Jones DP. Radical-free biology of oxidative stress. Am J Physiol Cell Physiol 295: C849-C868, 2008.
18. Jones DP, Go YM. Redox compartmentalization and cellular stress. Diabetes Obes Metab 12, Suppl 2: 116-125, 2010.
19. Kauntiz JD, Smith Cummins VP, Misler D, Nagami GT. Inhibition of gentamicin uptake into cultured mouse proximal tubule epitelial cells by L-lysine. J Clin Pharmacol 33: 63-69, 1993.
20. Khorooshi R, Owens T. Injury-induced type I IFN signaling regulates inflammatory responses in the central nervous system. J Immunol 185: 1258-1264, 2010.
21. Kinsey GR, Li L, Okusa MD. Inflammation in acute kidney injury. Nephron Exp Nephrol 109: e102-107, 2008.
22. Laitinen L, Virtanen I, Saxen L. Changes in the glycosylation pattern during embryonic development of mouse kidney as revealed with lectin conjugates. J Histochem Cytochem 35: 55-65, 1987.
23. Lassnigg A, Schmidlin D, Mouhieddine M, Bachmann LM, Druml W, Bauer P, Hiesmayr M. Minimal changes of serum creatinine predict prognosis in patients after cardiothoracic surgery: a prospective cohort study. J Am Soc Nephrol 15: 1597-1605, 2004.
24. Lee S, Huen S, Nishio H, Nishio S, Lee HK, Choi BS, Ruhrberg C, Cantley LG. Distinct macrophage phenotypes contribute to kidney injury and repair. J Am Soc Nephrol 22: 317-326, 2011.
25. Lemay S, Rabb H, Postler G, Singh AK. Prominent and sustained up-regulation of gp130-signaling cytokines and of the chemokine MIP 2 in murine renal ischemia-reperfusion injury. Transplantation 69: 959-963, 2000.
26. Li L, Huang L, Ye H, Song SP, Bajwa A, Lee SJ, Moser EK, Jaworska K, Kinsey GR, Day YJ, Linden J, Lobo PI, Rosin DL, Okusa MD. Dendritic cells tolerized with adenosine A2AR agonist attenuate acute kidney injury. J Clin Invest 122: 3931-3942, 2012.
27. Lin SL, Li B, Rao S, Yeo EJ, Hudson TE, Nowlin BT, Pei H, Chen L, Zheng JJ, Carroll TJ, Pollard JW, McMahon AP, Lang RA, Duffield JS. Macrophage Wnt7b is critical for kidney repair and regeneration. Proc Natl Acad Sci USA 107: 4194-4199, 2010.
28. Luan J, Furuta Y, Du J, Richmond A. Developmental expression of two CXC chemokines, MIP-2 and KC, and their receptors. Cytokine 14: 253-263, 2001.
29. Menke J, Iwata Y, Rabacal WA, Basu R, Yeung YG, Humphreys BD, Wada T, Schwarting A, Stanley ER, Kelley VR. CSF-1 signals directly to renal tubular epithelial cells to mediate repair in mice. J Clin Invest 119: 2330-2342, 2009.
30. Miura M, Fu X, Zhang QW, Remick DG, Fairchild RL. Neutralization of Gro alpha and macrophage inflammatory protein-2 attenuates renal ischemia/reperfusion injury. Am J Pathol 159: 2137-2145, 2001.
31. Molitoris BA. Transitioning to therapy in ischemic acute renal failure. J Am Soc Nephrol 14: 265-267, 2003.
32. Muller U, Steinhoff U, Reis LF, Hemmi S, Pavlovic J, Zinkernagel RM, Aguet M. Functional role of type I and type II interferons in antiviral defense. Science 264: 1918-1921, 1994.
33. Murugan R, Kellum JA. Acute kidney injury: what's the prognosis? Nat Rev Nephrol 7: 209-217, 2011.
34. Nath KA, Norby SM. Reactive oxygen species and acute renal failure. Am J Med 109: 665-678, 2000.
35. Paller MS, Neumann TV. Reactive oxygen species and rat renal epithelial cells during hypoxia and reoxygenation. Kidney Int 40: 1041-1049, 1991.
36. Pestka S, Krause CD, Walter MR. Interferons, interferon-like cytokines, and their receptors. Immunol Rev 202: 8-32, 2004.
37. Platanias LC. Mechanisms of type-I-and type-II-interferon-mediated signalling. Nat Rev Immunol 5: 375-386, 2005.
38. Rani MR, Ransohoff RM. Alternative and accessory pathways in the regulation of IFN-beta-mediated gene expression. J Interferon Cytokine Res 25: 788-798, 2005.
39. Ray PD, Huang BW, Tsuji Y. Reactive oxygen species (ROS) homeostasis and redox regulation in cellular signaling. Cell Signal 24: 981-990, 2012.
40. Reis LF, Ruffner H, Stark G, Aguet M, Weissmann C. Mice devoid of interferon regulatory factor 1 (IRF-1) show normal expression of type I interferon genes. EMBO J 13: 4798-4806, 1994.
41. Rifkin DE, Coca SG, Kalantar-Zadeh K. Does AKI truly lead to CKD? J Am Soc Nephrol 23: 979-984, 2012.
42. Schulte BA, Spicer SS. Histochemical evaluation of mouse and rat kidneys with lectin-horseradish peroxidase conjugates. Am J Anat 168: 345-362, 1983.
43. Shao X, Somlo S, Igarashi P. Epithelial-specific Cre/Lox recombination in the developing kidney and genitourinary tract. J Am Soc Nephrol 13: 1837-1846, 2002.
44. Shelton JM, Lee MH, Richardson JA, Patel SB. Microsomal triglyceride transfer protein expression during mouse development. J Lipid Res 41: 532-537, 2000.
45. Sutton TA, Fisher CJ, Molitoris BA. Microvascular endothelial injury and dysfunction during ischemic acute renal failure. Kidney Int 62: 1539-1549, 2002.
46. Tadagavadi RK, Reeves WB. Renal dendritic cells ameliorate nephrotoxic acute kidney injury. J Am Soc Nephrol 21: 53-63, 2010.
47. Tamura T, Yanai H, Savitsky D, Taniguchi T. The IRF family transcription factors in immunity and oncogenesis. Annu Rev Immunol 26: 535-584, 2008.
48. Taniguchi T, Ogasawara K, Takaoka A, Tanaka N. Irf family of transcription factors as regulators of host defense. Annu Rev Immunol 19: 623-655, 2001.
49. Thomas C, Moraga I, Levin D, Krutzik Peter O, Podoplelova Y, Trejo A, Lee C, Yarden G, Vleck Susan E, Glenn Jeffrey S, Nolan Garry P, Piehler J, Schreiber G, Garcia KC. Structural linkage between ligand discrimination and receptor activation by type I interferons. Cell 146: 621-632, 2011.
50. Thurman JM, Holers VM. The central role of the alternative complement pathway in human disease. J Immunol 176: 1305-1310, 2006.
51. Tian J, Barrantes F, Amoateng-Adjepong Y, Manthous CA. Rapid reversal of acute kidney injury and hospital outcomes: a retrospective cohort study. Am J Kidney Dis 53: 974-981, 2009.
52. Uchino S, Bellomo R, Bagshaw SM, Goldsmith D. Transient azotaemia is associated with a high risk of death in hospitalized patients. Nephrol Dial Transplant 25: 1833-1839, 2010.
53. Uze G, Schreiber G, Piehler J, Pellegrini S. The receptor of the type I interferon family. Curr Top Microbiol Immunol 316: 71-95, 2007.
54. van Pesch V, Lanaya H, Renauld JC, Michiels T. Characterization of the murine alpha interferon gene family. J Virol 78: 8219-8228, 2004.
55. Venkatachalam MA, Griffin KA, Lan R, Geng H, Saikumar P, Bidani AK. Acute kidney injury: a springboard for progression in chronic kidney disease. Am J Physiol Renal Physiol 298: F1078-F1094, 2010.
56. Wang Y, John R, Chen J, Richardson JA, Shelton JM, Bennett M, Zhou XJ, Nagami GT, Zhang Y, Wu QQ, Lu CY. IRF-1 promotes inflammation early after ischemic acute kidney injury. J Am Soc Nephrol 20: 1544-1555, 2009.
57. Wathelet MG, Lin CH, Parekh BS, Ronco LV, Howley PM, Maniatis T. Virus infection induces the assembly of coordinately activated transcription factors on the IFN-beta enhancer in vivo. Mol Cell 1: 507-518, 1998.
58. Zager RA, Fuerstenberg SM, Baehr PH, Myerson D, Torok-Storb B. An evaluation of antioxidant effects on recovery from postischemic acute renal failure. J Am Soc Nephrol 4: 1588-1597, 1994.
59. Zhai Y, Qiao B, Gao F, Shen X, Vardanian A, Busuttil RW, Kupiec-Weglinski JW. Type I, but not type II, interferon is critical in liver injury induced after ischemia and reperfusion. Hepatology 47: 199-206, 2008.
60. Zhang MZ, Yao B, Yang S, Jiang L, Wang S, Fan X, Yin H, Wong K, Miyazawa T, Chen J, Chang I, Singh A, Harris RC. CSF-1 signaling mediates recovery from acute kidney injury. J Clin Invest 122: 4519-4532, 2012.
61. Zhang Y, Woodward VK, Shelton JM, Richardson JA, Link DC, Zhou XJ, Kielar ML, Jeyarajah DR, Lu CY. Ischemia/reperfusion induces G-CSF gene expression by renal medullary thick ascending limb cells in vivo and in vitro. Am J Physiol Renal Physiol 286: F1193-F1201, 2004.